Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,743 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005-2022.
Oster C, Schmidt T, Agkatsev S, Lazaridis L, Kleinschnitz C, Sure U, Scheffler B, Kebir S, Glas M. Oster C, et al. Among authors: schmidt t. Neurooncol Adv. 2023 Sep 4;5(1):vdad105. doi: 10.1093/noajnl/vdad105. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37811538 Free PMC article. Review.
Hybrid 11C-MET PET/MRI Combined With "Machine Learning" in Glioma Diagnosis According to the Revised Glioma WHO Classification 2016.
Kebir S, Weber M, Lazaridis L, Deuschl C, Schmidt T, Mönninghoff C, Keyvani K, Umutlu L, Pierscianek D, Forsting M, Sure U, Stuschke M, Kleinschnitz C, Scheffler B, Colletti PM, Rubello D, Rischpler C, Glas M. Kebir S, et al. Among authors: schmidt t. Clin Nucl Med. 2019 Mar;44(3):214-220. doi: 10.1097/RLU.0000000000002398. Clin Nucl Med. 2019. PMID: 30516675
Regorafenib in patients with recurrent high-grade astrocytoma.
Kebir S, Rauschenbach L, Radbruch A, Lazaridis L, Schmidt T, Stoppek AK, Pierscianek D, Stuschke M, Forsting M, Sure U, Keyvani K, Kleinschnitz C, Scheffler B, Glas M. Kebir S, et al. Among authors: schmidt t. J Cancer Res Clin Oncol. 2019 Apr;145(4):1037-1042. doi: 10.1007/s00432-019-02868-5. Epub 2019 Feb 28. J Cancer Res Clin Oncol. 2019. PMID: 30820715
Comparison of L-Methyl-11C-Methionine PET With Magnetic Resonance Spectroscopy in Detecting Newly Diagnosed Glioma.
Kebir S, Lazaridis L, Weber M, Deuschl C, Stoppek AK, Schmidt T, Mönninghoff C, Blau T, Keyvani K, Umutlu L, Pierscianek D, Forsting M, Stuschke M, Antoch G, Sure U, Kleinschnitz C, Scheffler B, Colletti PM, Rubello D, Herrmann K, Glas M. Kebir S, et al. Among authors: schmidt t. Clin Nucl Med. 2019 Jun;44(6):e375-e381. doi: 10.1097/RLU.0000000000002577. Clin Nucl Med. 2019. PMID: 30985412
Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma.
Lazaridis L, Schäfer N, Teuber-Hanselmann S, Blau T, Schmidt T, Oster C, Weller J, Tzaridis T, Pierscianek D, Keyvani K, Kleinschnitz C, Stuschke M, Scheffler B, Deuschl C, Sure U, Herrlinger U, Kebir S, Glas M. Lazaridis L, et al. Among authors: schmidt t. J Cancer Res Clin Oncol. 2020 Mar;146(3):787-792. doi: 10.1007/s00432-019-03106-8. Epub 2019 Dec 11. J Cancer Res Clin Oncol. 2020. PMID: 31828428
Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial.
Guberina N, Pöttgen C, Kebir S, Lazaridis L, Scharmberg C, Lübcke W, Niessen M, Guberina M, Scheffler B, Jendrossek V, Jabbarli R, Pierscianek D, Sure U, Schmidt T, Oster C, Hau P, Grosu AL, Stuschke M, Glas M, Nour Y, Lüdemann L. Guberina N, et al. Among authors: schmidt t. Radiat Oncol. 2020 Apr 19;15(1):83. doi: 10.1186/s13014-020-01521-7. Radiat Oncol. 2020. PMID: 32307022 Free PMC article. Clinical Trial.
A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma.
Kebir S, Schmidt T, Weber M, Lazaridis L, Galldiks N, Langen KJ, Kleinschnitz C, Hattingen E, Herrlinger U, Lohmann P, Glas M. Kebir S, et al. Among authors: schmidt t. Cancers (Basel). 2020 Oct 22;12(11):3080. doi: 10.3390/cancers12113080. Cancers (Basel). 2020. PMID: 33105661 Free PMC article.
Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF-phase I/II trial.
Nour Y, Pöttgen C, Kebir S, Lazaridis L, Lüdemann L, Guberina M, Gauler T, Scheffler B, Jabbarli R, Pierscianek D, Sure U, Schmidt T, Oster C, Hau P, Glas M, Lübcke W, Stuschke M, Guberina N. Nour Y, et al. Among authors: schmidt t. J Appl Clin Med Phys. 2021 Jan;22(1):242-250. doi: 10.1002/acm2.13144. Epub 2021 Jan 3. J Appl Clin Med Phys. 2021. PMID: 33389825 Free PMC article. Clinical Trial.
Machine learning-based differentiation between multiple sclerosis and glioma WHO II°-IV° using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomography.
Kebir S, Rauschenbach L, Weber M, Lazaridis L, Schmidt T, Keyvani K, Schäfer N, Milia A, Umutlu L, Pierscianek D, Stuschke M, Forsting M, Sure U, Kleinschnitz C, Antoch G, Colletti PM, Rubello D, Herrmann K, Herrlinger U, Scheffler B, Bundschuh RA, Glas M. Kebir S, et al. Among authors: schmidt t. J Neurooncol. 2021 Apr;152(2):325-332. doi: 10.1007/s11060-021-03701-1. Epub 2021 Jan 27. J Neurooncol. 2021. PMID: 33502678
3,743 results